Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of MRV-MNP in Adults, Toddlers, and Infants
NCT04394689Phase 2Completed
- Sponsor
- Micron Biomedical
- Start
- May 2021
- Primary completion
- Nov 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of measles and rubella vaccine in measles, rubella, sponsored by Micron Biomedical. Started May 2021; status: completed.
02
Drugs
measles and rubella vaccine
03
Conditions
measlesrubella
Beyond the preview
Go deeper on NCT04394689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04394689.